Compound information
- Natural Products
- ZC784065
- Molecular Formula
- C12H10ClN3O2
- Molecular Weight
- 263.04615424 g/mol
- Structure
-
- IUPAC Name
- 2-chloro-N-(3-pyrazin-2-yloxyphenyl)acetamide
- InChI
- InChI=1S/C12H10ClN3O2/c13-7-11(17)16-9-2-1-3-10(6-9)18-12-8-14-4-5-15-12/h1-6,8H,7H2,(H,16,17)
- InChI Key
- OBEDAQWTJULQAK-UHFFFAOYSA-N
- SMILES
- O=C(CCl)Nc1cccc(Oc2cnccn2)c1
- Source
- ZINC000004108366
Warheads
- Halohydrocarbon
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 18 | Ring Count | 2 |
Heteroatom Count | 6 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 64.11 Å2 | LogP | 1.852 |
LogS | -2.74 | LogD | 1.629 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.05 | Pgp substrate | 0.091 |
HIA | 0.958 | F20 % | 0.962 |
F30 % | 0.612 | Caco-2 | -4.869 |
MDCK | -5.588 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.978 | PPB | 89.452 |
VD | 0.78 | Fu | 0.817 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 1.0 | CYP1A2 substrate | 0.82 |
CYP2A6 substrate | 0.517 | CYP2B6 substrate | 0.753 |
CYP2C19 inhibitor | 0.969 | CYP2C19 substrate | 0.85 |
CYP2C8 substrate | 0.771 | CYP2C9 inhibitor | 0.838 |
CYP2C9 substrate | 0.082 | CYP2D6 inhibitor | 0.824 |
CYP2D6 substrate | 0.506 | CYP2E1 substrate | 0.72 |
CYP3A4 inhibitor | 0.892 | CYP3A4 substrate | 0.795 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.824 | CL | 11.517 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.017 | Hepatotoxicity | 0.86 |
Mutagenicity | 0.007 | Rat Oral Acute Toxicity | 0.731 |
FDAMDD | 0.491 | Skin Sensitization | 1.0 |
Carcinogenicity | 0.329 | Eye Corrosion | 0.004 |
Eye Irritation | 0.348 | Respiratory Toxicity | 0.991 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.685 | IGC50 | 3.36 |
LC50FM | 4.112 | LC50DM | 5.013 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.231 | NR-AR-LBD | 0.378 |
NR-AhR | 0.87 | NR-Aromatase | 0.449 |
NR-ER | 0.648 | NR-ER-LBD | 0.562 |
NR-PPAR-gamma | 0.923 | SR-ARE | 0.978 |
SR-ATAD5 | 0.894 | SR-HSE | 0.927 |
SR-MMP | 0.291 | SR-p53 | 0.879 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.